TNDM
TANDEM DIABETES CARE INC
NASDAQ · Healthcare · Medical - Devices · US
$16.87
−2.09%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- $266.1M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.31
- EPS estimate
- -$0.32
- Revenue actual
- $254.6M
- Revenue estimate
- $255.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +29.5%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $21
- PT range
- $16 – $26
- Analysts
- 5
2 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.32 | -$0.31 | Beat 3.35% | $254.6M |
| May 7, 2026 | -$0.46 | -$0.30 | Beat 34.78% | $247.2M |
| Feb 19, 2026 | -$0.05 | -$0.01 | Beat 80.00% | $290.4M |
| Nov 6, 2025 | -$0.31 | -$0.31 | In line | $249.3M |
| Aug 6, 2025 | -$0.40 | -$0.48 | Miss -20.00% | $240.7M |
| Apr 30, 2025 | -$0.60 | -$0.67 | Miss -11.67% | $234.4M |
| Feb 26, 2025 | -$0.25 | -$0.44 | Miss -76.00% | $282.6M |
| Aug 1, 2024 | -$0.54 | -$0.47 | Beat 12.96% | $221.9M |
| May 2, 2024 | -$0.80 | -$0.63 | Beat 21.25% | $191.7M |
| Feb 21, 2024 | -$0.23 | -$0.27 | Miss -17.39% | $196.8M |
| Nov 1, 2023 | -$0.35 | -$0.38 | Miss -8.57% | $185.6M |
| Aug 3, 2023 | -$0.54 | -$0.30 | Beat 44.44% | $195.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026